Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Fuji
Accenture
AstraZeneca
Cerilliant
Covington
Harvard Business School
Colorcon
Deloitte

Generated: May 23, 2018

DrugPatentWatch Database Preview

Chlorhexidine gluconate - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for chlorhexidine gluconate and what is the scope of chlorhexidine gluconate freedom to operate?

Chlorhexidine gluconate
is the generic ingredient in twenty-seven branded drugs marketed by Xttrium, Sage Prods, Apotex Inc, Hi Tech Pharma, Lyne, Teva, Wockhardt Bio Ag, Sunstar Americas, 3M, Colgate Palmolive Co, Colgate-palmolive Co, Soapco, Ecolab, Bajaj Medical Llc, Molnlycke Hlth, J And J, Matrix Medcl, Griffen, Becton Dickinson, Kendall Il, Carefusion 2200, Dexcel Pharma, Becton Dickinson Co, and Prof Dspls, and is included in thirty-four NDAs. There are eleven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Chlorhexidine gluconate has three patent family members in one country.

There are fifty-seven drug master file entries for chlorhexidine gluconate. Sixty-four suppliers are listed for this compound.
Pharmacology for chlorhexidine gluconate
Physiological EffectDecreased Cell Wall Integrity
Medical Subject Heading (MeSH) Categories for chlorhexidine gluconate
Synonyms for chlorhexidine gluconate
(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine; (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoic acid
1-(4-chlorophenyl)-3-[N-[6-[[N-[N-(4-chlorophenyl)carbamimidoyl]carbamimidoyl]amino]hexyl]carbamimidoyl]guanidine; (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoic acid
1,1'-Hexamethylene bis(5-(p-chlorophenyl)biguanide), digluconate
1,1'-Hexamethylenebis[5-(4-chlorophenyl)biguanide] Digluconate
1,6-Bis(N5-[p-chlorophenyl]-N1-biguanido)hexane; 1,1 inverted exclamation marka-Hexamethylenebis(5-[p-chlorophenyl]biguanide)
1,6-Bis(N5-[p-chlorophenyl]-N1-biguanido)hexane; 1,1'-Hexamethylenebis(5-[p-chlorophenyl]biguanide)
105791-72-8
12068-31-4
124973-71-3
14007-07-9
150621-85-5
151498-43-0
18472-51-0
2,4,11,13-Tetraazatetradecanediimidamide, N,N''-bis(4-chlorophenyl)-3,12-diimino-, digluconate
21293-24-3
227749-99-7
230296-52-3
23289-58-9
40330-16-3
452971-25-4
51365-13-0
52196-45-9
52387-19-6
60042-57-1
60404-86-6
82432-16-4
906339-38-6
Abacil
AKOS015896303
AKOS025310696
AN-18792
Arlacide G
Bioscrub
Brian Care
C08038
CHEBI:28312
Chlorhexidin glukonatu
Chlorhexidine D-digluconate
Chlorhexidine di-D-gluconate
CHLORHEXIDINE DIGLUCONATE
Chlorhexidine digluconate solution
Chlorhexidine digluconate solution, 20% in H2O
Chlorhexidine digluconate, 20% w/v aqueous solution
Chlorhexidine digluconate, pharmaceutical secondary standard; traceable to USP and PhEur
Chlorhexidine gluconate (JP17/USP)
Chlorhexidine gluconate [USAN:USP:JAN]
Chx plus concentrate premium chlorhexidine teat dip concentrate
Cida-Stat
D-Gluconic acid, compd with N,N''-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide (2:1)
D-Gluconic acid, compd. with N,N''-bis(4-chlorophenyl) -3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide (2:1)
D-Gluconic acid, compd. with N1,N14-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide (2:1)
D00858
DTXSID5034519
Dyna-hex
EC 242-354-0
Exidine
Fight bac
Gluconic acid, compd. with 1,1'-hexamethylene bis(5-(p-chlorophenyl)biguanide) (2:1), D- (8CI)
Hibiclens
Hibiclens (TN)
Hibidil
Hibiscrub
Hibitane
Hibitane gluconate
I06-2074
J-011837
Kleersight
M166
MFCD00083599
Microderm
MolPort-006-069-426
MOR84MUD8E
N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)]--D-gluconic acid (1/2)
Peridex
Peridex (TN)
Periochip
Periogard
Periogard (TN)
Pharmaseal Scrub Care
pHiso-Med
Prevacare
Prevacare R
SCHEMBL34468
Steri-Stat
UNII-MOR84MUD8E
Unisept

US Patents and Regulatory Information for chlorhexidine gluconate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Becton Dickinson Co CHLORAPREP WITH TINT chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-005 Apr 3, 2006 OTC Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Becton Dickinson Co CHLORAPREP WITH TINT chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-002 May 3, 2005 OTC Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Becton Dickinson Co CHLORAPREP WITH TINT chlorhexidine gluconate; isopropyl alcohol SPONGE;TOPICAL 020832-005 Apr 3, 2006 OTC Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Becton Dickinson Co CHLORAPREP TRIPLE SWABSTICK chlorhexidine gluconate; isopropyl alcohol SWAB;TOPICAL 021555-003 Jun 10, 2009 OTC Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for chlorhexidine gluconate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dexcel Pharma PERIOCHIP chlorhexidine gluconate TABLET;DENTAL 020774-001 May 15, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Molnlycke Hlth HIBICLENS chlorhexidine gluconate SPONGE;TOPICAL 018423-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Molnlycke Hlth HIBICLENS chlorhexidine gluconate SOLUTION;TOPICAL 017768-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Dexcel Pharma PERIOCHIP chlorhexidine gluconate TABLET;DENTAL 020774-001 May 15, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for chlorhexidine gluconate

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,221,365 Disinfectant delivery system, and method of providing alcohol-free disinfection ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Johnson and Johnson
Covington
US Department of Justice
AstraZeneca
Chubb
Cipla
Federal Trade Commission
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.